Zhu S - Search Results

1

Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.

Shang Z, Zhu S, Zhang H, Li L, Niu Y. Shang Z, et al. Among authors: zhu s. Eur Urol. 2013 Jul;64(1):173-6. doi: 10.1016/j.eururo.2013.03.007. Epub 2013 Mar 14. Eur Urol. 2013. PMID: 23518396 Review. No abstract available.

2

DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Zhu S, Zhang H, Tang Y, Liu P, Wang J. Zhu S, et al. Mol Biol Rep. 2012 Apr;39(4):4429-37. doi: 10.1007/s11033-011-1231-2. Epub 2011 Sep 22. Mol Biol Rep. 2012. PMID: 21938431

3

Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.

Zhang H, Zhu S, Chen J, Tang Y, Hu H, Mohan V, Venkatesan R, Wang J, Chen H. Zhang H, et al. Among authors: zhu s. Diabetes Care. 2012 Jun;35(6):1388-93. doi: 10.2337/dc11-2142. Diabetes Care. 2012. PMID: 22619290 Free PMC article.

4

Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.

Zhu S, Zhang H, Tang Y, Wang J. Zhu S, et al. Urol Int. 2012;89(2):233-40. doi: 10.1159/000339603. Epub 2012 Aug 11. Urol Int. 2012. PMID: 22890093

5

Risk factors and prevention of inguinal hernia after radical prostatectomy: a systematic review and meta-analysis.

Zhu S, Zhang H, Xie L, Chen J, Niu Y. Zhu S, et al. J Urol. 2013 Mar;189(3):884-90. doi: 10.1016/j.juro.2012.08.241. Epub 2012 Sep 23. J Urol. 2013. PMID: 23009871 Review.

6

HoxB3 promotes prostate cancer cell progression by transactivating CDCA3.

Chen J, Zhu S, Jiang N, Shang Z, Quan C, Niu Y. Chen J, et al. Among authors: zhu s. Cancer Lett. 2013 Apr 28;330(2):217-24. doi: 10.1016/j.canlet.2012.11.051. Epub 2012 Dec 5. Cancer Lett. 2013. PMID: 23219899

7

Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells.

Wen S, Shang Z, Zhu S, Chang C, Niu Y. Wen S, et al. Among authors: zhu s. Prostate. 2013 Sep;73(12):1306-15. doi: 10.1002/pros.22676. Epub 2013 Jun 15. Prostate. 2013. PMID: 23775364

8

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies.

Zhu S, Tang Y, Li K, Shang Z, Jiang N, Nian X, Sun L, Niu Y. Zhu S, et al. BMC Cancer. 2013 Jul 5;13:332. doi: 10.1186/1471-2407-13-332. BMC Cancer. 2013. PMID: 23829273 Free PMC article.

9

A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.

Jiang N, Zhu S, Chen J, Niu Y, Zhou L. Jiang N, et al. Among authors: zhu s. PLoS One. 2013 Oct 9;8(10):e74386. doi: 10.1371/journal.pone.0074386. eCollection 2013. PLoS One. 2013. PMID: 24130666 Free PMC article.

10

Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: evidence from meta-analysis.

Sun L, Zhu S, Zhao Y, Zhang H, Shang Z, Jiang N, Li G, Niu Y. Sun L, et al. Among authors: zhu s. Tumour Biol. 2014 Oct;35(10):9911-8. doi: 10.1007/s13277-014-2297-y. Epub 2014 Jul 6. Tumour Biol. 2014. PMID: 24997620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,769 results

Search Page

Filters